Skip to main content
Caplight Logo









BioNova Pharmaceuticals (Shanghai) Ltd.

BioNova Pharmaceuticals (Shanghai) Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://bionovapharma.com

Last Round

Series B

Extension

Nov 23, 2020

Total Funding Raised

$17M

Company Overview

BioNova Pharmaceuticals (Shanghai) Ltd. is a biotechnology company that manufactures innovative drugs designed to advance clinical treatment for cancer and life-threatening diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCsmall moleculesoncologydrug pipelinedrug in-licensingdrug developmentclinical stage biotechhematologic oncologyChina pharma marketmenin inhibitorCD74-targeting ADCgraft-versus-host diseaseGVHDBTK inhibitorROCK2 inhibitoracute leukemiaAI-augmented drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioNova Pharmaceuticals (Shanghai) Ltd. Comparables

Compare BioNova Pharmaceuticals (Shanghai) Ltd. with similar companies based on industry and business-model similarity.

BioNova Pharmaceuticals (Shanghai) Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Innolake Biopharm
72%
Sutro Biopharma Inc
70%
Syndax Pharmaceuticals
69%

BioNova Pharmaceuticals (Shanghai) Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionNov 23, 2020
Series BAug 1, 2020
Series ADec 25, 2018

Key People

Founding team and executive leadership

Ye Hua

Chairman & CEO

Executive Team

BioNova Pharmaceuticals (Shanghai) Ltd. Investors

Notable investors and investment history

BioNova Pharmaceuticals (Shanghai) Ltd. investors
InvestorRounds
BioTrack CapitalSeries B
Mitsui Global InvestmentSeries B
TF CapitalSeries A
Rencent CapitalSeries B Extension
OrbiMedSeries B
Medfine CapitalSeries B
Lilly Asia VenturesSeries B

BioNova Pharmaceuticals (Shanghai) Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioNova Pharmaceuticals (Shanghai) Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioNova Pharmaceuticals (Shanghai) Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range11
Year Founded2018
Last FundingNov 23, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?